reduct myocardi infarct size poloxam mannitol canin model poloxam thrombosi decreas whole blood viscos perfus tissu mannitol free radic scaveng capabl myocardi salvag ischemia agent differ way cardioprotect properti combin minut left anterior coronari arteri lad occlus dog poloxam mg/kg gm/kg addit minut lad occlus minut reperfus control dog equal volum salin solut surgeri anim hour area myocardi infarct MI risk infarct mean planimetr analysi slice myocardium triphenyltetrazolium evan blue dye ratio mi/r mean standard error mean control mannitol measur microvascular blood flow similar reduct blood flow area risk treatment group poloxam salvag ischem myocardium combin effect agent 